Common Contracts

STOCK PURCHASE AGREEMENT by and among ORGENESIS INC., GPP-II MASTHERCELL, LLC, MASTHERCELL GLOBAL INC., AND CATALENT PHARMA SOLUTIONS, INC. Dated as of February 2, 2020

Stock Purchase Agreement • February 3rd, 2020 • Orgenesis Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Stock Purchase Agreement
• Filed
  February 3rd, 2020
• Company
  Orgenesis Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This STOCK PURCHASE AGREEMENT, dated as of February 2, 2020 (this "Agreement"), is entered into by and among Orgenesis Inc., a Nevada corporation ("Seller One"), GPP-II Masthercell, LLC, a Delaware limited liability company ("Seller Two," and together with Seller One, the "Sellers," and each a "Seller"), Masthercell Global Inc., a Delaware corporation (the "Company"), and Catalent Pharma Solutions, Inc., a Delaware corporation ("Buyer").

STOCK PURCHASE AGREEMENT by and among ORGENESIS INC., GPP-II MASTHERCELL, LLC, MASTHERCELL GLOBAL INC., AND CATALENT PHARMA SOLUTIONS, INC. Dated as of February 2, 2020

Stock Purchase Agreement • February 3rd, 2020 • Catalent, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Stock Purchase Agreement
• Filed
  February 3rd, 2020
• Company
  Catalent, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This STOCK PURCHASE AGREEMENT, dated as of February 2, 2020 (this “Agreement”), is entered into by and among Orgenesis Inc., a Nevada corporation (“Seller One”), GPP-II Masthercell, LLC, a Delaware limited liability company (“Seller Two,” and together with Seller One, the “Sellers,” and each a “Seller”), Masthercell Global Inc., a Delaware corporation (the “Company”), and Catalent Pharma Solutions, Inc., a Delaware corporation (“Buyer”).